Drug profile · INN
terbinafine
APO-TERBINAFINE
terbinafine (APO-TERBINAFINE) is a squalene monooxygenase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: topical. Current US regulatory status: approved.
Drug details — terbinafine
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 4
- Data quality
- 0.84
Quick answer
terbinafine (APO-TERBINAFINE) is a squalene monooxygenase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Squalene monooxygenase inhibitor
Primary target: Squalene monooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is terbinafine?
terbinafine (APO-TERBINAFINE) is a squalene monooxygenase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for terbinafine?
APO-TERBINAFINE is a marketed brand name for terbinafine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of terbinafine?
terbinafine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.